1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Biologics Development
  6.  » Accelerating Biologics And Biosimilar Development
Accelerating Biologics And Biosimilar Development
Summary: Get to know how Catalent’s scientists have utilized ambr 15® as a micro-scale model for a synergistic clonal and process screen to identify the master cell bank candidates. Using this multi-layered approach, early in the development process significantly improves selection of top clones while shortening the overall timeline.

Click here to view webinar.